Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

Abstract Background The optimal time cut-off for appropriate antibiotic therapy (AAT) in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia remains uncertain. We assessed the effects of time to AAT on 30-day in-hospital mortality in patients with MRSA bacteremia who received glycopeptides...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tae-Hoon No, Seok Jun Mun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-11-01
coleção:	BMC Infectious Diseases
Assuntos:	Methicillin-resistant staphylococcus aureus Bacteremia Glycopeptides Treatment outcome Time factors
Acesso em linha:	https://doi.org/10.1186/s12879-025-12040-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!